Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
My body lacked some chemical combo others had, and thus assumed everyone had
One example from each of the common diabetes classes is listen in Table 4 since other medications in the same class typically have similar costs
This month's Broker Brief breaks down: - Why up to 65% of GLP-1 users discontinue within a year, and why that turns coverage into a sunk cost for employers - What oral GLP-1s like Lilly's Foundayo mean for demand, when most plans still have eligibility rules written for injectables only - How fast a PBM formulary decision can move, using this year's Zepbound to Wegovy switch and back as the case in point - Why 38% of employers already tie GLP-1 coverage to participation in a lifestyle or behavioral program If you're advising employers on GLP-1 coverage, this is where the conversation is heading
PlexusDx aims to make this personalized context accessible and interpretable
Even among neurologists, 8 percent had prescribed GLP-1RAs to treat Parkinsons disease, and 20 percent had prescribed GLP-1RAs to treat Alzheimers disease
US$ 29.21
US$ 25.67
US$ 26.89
US$ 22.82
US$ 25.66
